AIM
NVAX icon

Achmea Investment Management’s Novavax NVAX Stock Holding History

Achmea Investment Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,433
Closed -$279K – 663
2022
Q2 		$279K Sell
5,433
-886
-14% -$45.9K 0.01% 525
2022
Q1 		$465K Buy
+6,319
New +$563K 0.01% 532
2021
Q4 		– Sell
-7,111
Closed -$1.47M – 452
2021
Q3 		$1.47M Buy
7,111
+144
+2% +$31.7K 0.04% 386
2021
Q2 		$1.48M Buy
+6,967
New +$1.28M 0.05% 378

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Achmea Investment Management's NVAX Position: Q3 2022 in Review

Achmea Investment Management sold out of Novavax (NVAX) in Q3 2022, closing a stake of 5,433 shares — an estimated $279K sold.

Achmea Investment Management first reported a position in NVAX in Q2 2021 and held it in 4 quarters. The position peaked at $1.48M in Q2 2021. 253 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.

  • Achmea Investment Management reported no remaining Novavax position as of Q3 2022 after selling out during the quarter.
  • Achmea Investment Management sold 5,433 Novavax shares in Q3 2022, an estimated $279K.
  • Achmea Investment Management first reported a position in Novavax in Q2 2021 and held it in 4 quarters.
  • Achmea Investment Management's Novavax position peaked at $1.48M in Q2 2021.
  • 253 funds tracked by Wall St. Rank held Novavax as of Q3 2022.

Based on Achmea Investment Management's 13F filing for Q3 2022, filed 27 Oct 2022.